INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

May 14, 2024

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Head and Neck Squamous Cell Carcinoma (HNSCC)
Interventions
DRUG

INBRX-106

INBRX-106 by intravenous (IV) infusion, given every 3 weeks (QW3)

DRUG

Pembrolizumab

Pembrolizumab 200 mg by intravenous (IV) infusion, given every 3 weeks (QW3)

Trial Locations (78)

1090

RECRUITING

University Hospital Brussels, Jette

1527

RECRUITING

Uni Multiprofile Hospital for Active Treatment Tsaritsa Yoanna - ISUL EAD Clinic of Medical Oncology, Sofia

1618

RECRUITING

Multiprofile Hospital for Active Treatment Sveta Sofia, Department of Medical Oncology, Sofia

2650

RECRUITING

Antwerp University Hospital, Edegem

4004

RECRUITING

Complex Oncological Center Plovdiv EOOD Dept of Med Oncology and Oncological Diseases in Hematology, Plovdiv

4500

RECRUITING

"Multiprofile Hospital for Active Treatment - Uni Hospital Ltd, Medical Oncology Dept", Panagyurishte

5000

RECRUITING

Royal Adelaide Hospital, Adelaide

RECRUITING

Chu Ucl Namur Site De Sainte-Elisabeth, Namur

9100

RECRUITING

Vitaz, Sint-Niklaas

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

15006

RECRUITING

Complexo Hospitalario Universitario A Coruña, A Coruña

15232

RECRUITING

UPMC Hillman Cancer Center, Pittsburgh

15706

RECRUITING

Hospital Clinico Universitario de Santiago de Compostela, Santiago

16150

RECRUITING

Hospital Universiti Sains Malaysia, Kubang Kerian

19713

RECRUITING

ChristianaCare Health Services, Newark

20141

RECRUITING

European Institute of Oncology, Milan

21565

RECRUITING

Gachon University Gil Medical Center of Korea, Seoul

23298

RECRUITING

VCU Massey Comprehensive Cancer Center, Richmond

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

28033

RECRUITING

MD Anderson Cancer Centre, Madrid

31008

RECRUITING

Hospital Universitario de Navarra, Pamplona

32608

RECRUITING

University of Florida UF Health Cancer Center, Gainesville

32763

RECRUITING

Mid Florida Hematology and Oncology Center, Orange City

33169

RECRUITING

The Oncology Institute of Hope & Innovation, Miami

33331

RECRUITING

Cleveland Clinic Florida, The Maroone Cancer Center, Weston

40202

RECRUITING

Norton Cancer Institute, Louisville

42601

RECRUITING

Keimyung University Dongsan Hospital of Korea, Daegu

48201

RECRUITING

Karmanos Cancer Institute, Detroit

50612

RECRUITING

Pusan National University Yangsan Hospital, Yangsan

56000

RECRUITING

Hospital Canselor Tuanku Muhriz (HCTM) UKM, Cheras

57000

RECRUITING

UNEOS-Hopital R.SCHUMAN, Metz

59102

RECRUITING

Intermountain Health, St. Vincent Regional Hospital, Cancer Centers of Montana, Billings

60612

RECRUITING

University of Illinois Cancer Center, Chicago

62250

RECRUITING

Institut Kanser Negara, Putrajaya

63110

RECRUITING

Washington University St. Louis, St Louis

68130

RECRUITING

Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha

69008

RECRUITING

Centre Leon Berard, Lyon

73104

RECRUITING

Oklahoma University Stephenson Cancer Center, Oklahoma City

74370

RECRUITING

CH Annecy Genevois, Annecy

78404

RECRUITING

CHRISTUS Spohn Cancer Center, Corpus Christi

80756

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

87505

RECRUITING

Christus St. Vincent Regional Cancer Center, Santa Fe

89169

RECRUITING

Comprehensive Cancer Centers of Nevada, Las Vegas

90403

RECRUITING

Sarcoma Oncology Center, Santa Monica

91010

RECRUITING

City of Hope Medical Center, Duarte

91204

RECRUITING

Los Angeles Cancer Network (LACN), Los Angeles

92123

RECRUITING

Medical Oncology Associates of San Diego, San Diego

93586

RECRUITING

Sarawak General Hospital, Kuching

95816

RECRUITING

Sutter Health, Sacramento

95817

RECRUITING

UC Davis, Sacramento

97239

RECRUITING

Oregon Health & Science University, Portland

100226

RECRUITING

National Taiwan University Hospital, Taipei

200385

RECRUITING

Sc Oncolab Srl, Craiova

200745

RECRUITING

Sc Centrul de Oncologie Sf Nectarie Srl, Craiova

400015

RECRUITING

"Arensia Exploratory Medicine S.R.L in collaboration with Prof. Dr. Ion Chiricuta Oncology Institute", Cluj-Napoca, Cluj

407219

RECRUITING

Taichung Veterans General Hospital, Taichung

02114

RECRUITING

Massachusetts General Hospital, Boston

27599-7305

RECRUITING

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

44-102

RECRUITING

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy Oddział w Gliwicach, Gliwice

62-500

RECRUITING

Przychodnia Lekarska KOMED, Konin

97-300

RECRUITING

Provita Profamilia, Piotrkow Trybunalski

022328

RECRUITING

ARENSIA Clinic Oncology Institute Bucharest, Bucharest

01812

RECRUITING

Korea Cancer Center Hospital, Seoul

02841

RECRUITING

Korea University Anam Hospital, Seoul

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

08308

RECRUITING

Korea University Guro Hospital, Seoul

08908

RECRUITING

Intituto Catalán de Oncología, Barcelona

08023

RECRUITING

IOB / Institute of Oncology, Hospital Quirónsalud Barcelona, Barcelona

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

Unknown

RECRUITING

Hospital Universitario y Politécnico La Fe, Valencia

SW36JJ

RECRUITING

The Royal Marsden NHS Foundation Trust, Chelsea, Chelsea

HA6 2RN

RECRUITING

Mount Vernon Cancer Centre, Northwood

NE7 7DN

RECRUITING

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne

SM25PT

RECRUITING

The Royal Marsden NHS Foundation Trust, Sutton, Sutton

AB25 2ZN

RECRUITING

NHS Grampian / Aberdeen Royal Infirmary, Aberdeen

CB2 0QQ

RECRUITING

Addenbrooke's Hospital, Cambridge

M204BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

NR47UY

RECRUITING

Norwich and Norfolk University Hospital, Norwich

Sponsors
All Listed Sponsors
lead

Inhibrx Biosciences, Inc

INDUSTRY

NCT06295731 - INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC | Biotech Hunter | Biotech Hunter